• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

失代偿性心力衰竭和利尿剂抵抗患者的早期超滤治疗

Early ultrafiltration in patients with decompensated heart failure and diuretic resistance.

作者信息

Costanzo Maria Rosa, Saltzberg Mitchell, O'Sullivan Jeanne, Sobotka Paul

机构信息

Midwest Heart Foundation, Lombard, Illinois, USA.

出版信息

J Am Coll Cardiol. 2005 Dec 6;46(11):2047-51. doi: 10.1016/j.jacc.2005.05.099. Epub 2005 Nov 9.

DOI:10.1016/j.jacc.2005.05.099
PMID:16325040
Abstract

OBJECTIVES

We sought to determine if ultrafiltration before intravenous (IV) diuretics in patients with decompensated heart failure and diuretic resistance results in euvolemia and early discharge without hypotension or worsening renal function.

BACKGROUND

Heart failure patients with renal insufficiency and diuretic resistance have increased hospital mortality and length of stay. Peripheral veno-venous ultrafiltration may re-establish euvolemia and diuretic responsiveness.

METHODS

Ultrafiltration was initiated within 4.7 +/- 3.5 h of hospitalization and before IV diuretics in 20 heart failure patients with volume overload and diuretic resistance (age 74.5 +/- 8.2 years; 75% ischemic disease; ejection fraction 31 +/- 15%) and continued until euvolemia. Re-evaluation was each hospital day, at 30 days, and at 90 days.

RESULTS

A total of 8,654 +/- 4,205 ml were removed with ultrafiltration. Twelve patients (60%) were discharged in < or =3 days. One patient was readmitted in 30 days. Weight (p = 0.006), Minnesota Living with Heart Failure scores (p = 0.003), and Global Assessment (p = 0.00003) improved after ultrafiltration and at 30 and 90 days. Median B-type natriuretic peptide levels decreased after ultrafiltration (from 1,230 pg/ml to 788 pg/ml) and at 30 days (815 pg/ml) (p = 0.035). Blood pressure, renal function, and medications were unchanged.

CONCLUSIONS

In heart failure patients with volume overload and diuretic resistance, ultrafiltration before IV diuretics effectively and safely decreases length of stay and readmissions. Clinical benefits persist at three months.

摘要

目的

我们试图确定,对于失代偿性心力衰竭且存在利尿剂抵抗的患者,在静脉注射利尿剂之前进行超滤是否能实现血容量正常并早期出院,同时不会出现低血压或肾功能恶化。

背景

伴有肾功能不全和利尿剂抵抗的心力衰竭患者,其医院死亡率和住院时间均增加。外周静脉 - 静脉超滤可能会重建血容量正常状态和利尿剂反应性。

方法

对20例存在容量超负荷和利尿剂抵抗的心力衰竭患者(年龄74.5±8.2岁;75%为缺血性疾病;射血分数31±15%)在住院4.7±3.5小时内且在静脉注射利尿剂之前开始进行超滤,并持续至血容量正常。每天、30天和90天时进行重新评估。

结果

通过超滤共清除8654±4205毫升。12例患者(60%)在≤3天内出院。1例患者在30天内再次入院。超滤后以及在30天和90天时,体重(p = 0.006)、明尼苏达心力衰竭生活评分(p = 0.003)和整体评估(p = 0.00003)均有所改善。超滤后(从1230皮克/毫升降至788皮克/毫升)以及30天时(815皮克/毫升),B型利钠肽水平中位数下降(p = 0.035)。血压及肾功能及用药情况未发生变化。

结论

对于存在容量超负荷和利尿剂抵抗的心力衰竭患者,在静脉注射利尿剂之前进行超滤可有效且安全地缩短住院时间和再入院率。临床益处持续三个月。

相似文献

1
Early ultrafiltration in patients with decompensated heart failure and diuretic resistance.失代偿性心力衰竭和利尿剂抵抗患者的早期超滤治疗
J Am Coll Cardiol. 2005 Dec 6;46(11):2047-51. doi: 10.1016/j.jacc.2005.05.099. Epub 2005 Nov 9.
2
Ultrafiltration for the treatment of diuretic-resistant, recurrent, acute decompensated heart failure: experience in a single center.超滤治疗利尿剂抵抗、反复发作的急性失代偿性心力衰竭:单中心经验。
J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):599-604. doi: 10.2459/JCM.0b013e3283383275.
3
[Use of intermittent ultrafiltration in decompensated, diuretic-resistant heart failure--six case reports].[间歇性超滤在失代偿性、利尿剂抵抗性心力衰竭中的应用——6例报告]
Kardiol Pol. 2008 Nov;66(11):1202-4.
4
Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD.超滤治疗相较于持续利尿剂输注能减少失代偿性心力衰竭患者的再住院率:来自 UNLOAD 的研究结果。
J Card Fail. 2010 Apr;16(4):277-84. doi: 10.1016/j.cardfail.2009.12.009. Epub 2010 Feb 4.
5
The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.腺苷A1受体拮抗剂KW-3902对急性失代偿性心力衰竭合并肾功能损害或利尿剂抵抗患者利尿及肾功能的影响
J Am Coll Cardiol. 2007 Oct 16;50(16):1551-60. doi: 10.1016/j.jacc.2007.07.019. Epub 2007 Oct 1.
6
Cardiac efficiency improvement after slow continuous ultrafiltration is assessed by beat-to-beat minimally invasive monitoring in congestive heart failure patients: a preliminary report.在充血性心力衰竭患者中,通过逐拍微创监测评估缓慢连续超滤后的心脏效率改善:初步报告。
Blood Purif. 2010;29(1):44-51. doi: 10.1159/000258552. Epub 2009 Nov 12.
7
Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial.超滤与常规治疗对住院心力衰竭患者的疗效比较:急性液体超负荷失代偿性充血性心力衰竭患者缓解(RAPID-CHF)试验
J Am Coll Cardiol. 2005 Dec 6;46(11):2043-6. doi: 10.1016/j.jacc.2005.05.098. Epub 2005 Nov 4.
8
Cost-consequences of ultrafiltration for acute heart failure: a decision model analysis.急性心力衰竭超滤治疗的成本后果:一项决策模型分析
Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):566-73. doi: 10.1161/CIRCOUTCOMES.109.853556. Epub 2009 Nov 3.
9
Acute decompensated heart failure and the cardiorenal syndrome.急性失代偿性心力衰竭与心肾综合征
Crit Care Med. 2008 Jan;36(1 Suppl):S75-88. doi: 10.1097/01.CCM.0000296270.41256.5C.
10
Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.急性失代偿性心力衰竭的消肿治疗:超滤和利尿剂的心脏肾脏影响。
Am J Kidney Dis. 2011 Dec;58(6):1005-17. doi: 10.1053/j.ajkd.2011.07.023. Epub 2011 Oct 19.

引用本文的文献

1
Heart Failure-Focus on Kidney Replacement Therapy: Why, When, and How?心力衰竭——聚焦肾脏替代治疗:为何、何时以及如何进行?
Int J Mol Sci. 2025 Mar 10;26(6):2456. doi: 10.3390/ijms26062456.
2
Diuretic treatment using the RenalGuard® system in patients hospitalized due to acute decompensated heart failure and characterization of the profile of patients with good and poor response to treatment - preliminary study.使用RenalGuard®系统对因急性失代偿性心力衰竭住院的患者进行利尿治疗以及对治疗反应良好和不佳患者的特征分析——初步研究
Cardiol J. 2025;32(1):43-52. doi: 10.5603/cj.102386. Epub 2024 Nov 21.
3
Development of a new miniaturized system for ultrafiltration.
开发一种新型的超滤微型化系统。
Heart Fail Rev. 2024 May;29(3):615-630. doi: 10.1007/s10741-024-10384-z. Epub 2024 Jan 30.
4
Ultrafiltration in Heart Failure: A Review.心力衰竭中的超滤:综述
Cureus. 2023 Jun 4;15(6):e39933. doi: 10.7759/cureus.39933. eCollection 2023 Jun.
5
The Efficacy and Safety of Short-Term Tolvaptan Usage in Patients with Acute Decompensated Heart Failure.短期使用托伐普坦治疗急性失代偿性心力衰竭患者的疗效与安全性
Acta Cardiol Sin. 2022 Nov;38(6):700-713. doi: 10.6515/ACS.202211_38(6).20220422A.
6
Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment.1型心肾综合征肾功能恶化的见解:从发病机制、生物标志物到治疗
Front Cardiovasc Med. 2021 Dec 14;8:760152. doi: 10.3389/fcvm.2021.760152. eCollection 2021.
7
Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial.早期超滤治疗容量超负荷的急性失代偿性心力衰竭患者的疗效和安全性:一项前瞻性、随机、对照临床试验。
BMC Cardiovasc Disord. 2020 Oct 14;20(1):447. doi: 10.1186/s12872-020-01733-5.
8
Early continuous ultrafiltration in Chinese patients with congestive heart failure (EUC-CHF): study protocol for an open-label registry-based prospective clinical trial.早期持续超滤治疗中国充血性心力衰竭患者(EUC-CHF):一项基于开放性登记前瞻性临床试验的研究方案。
BMC Cardiovasc Disord. 2019 Nov 7;19(1):249. doi: 10.1186/s12872-019-1208-y.
9
Ultrafiltration by Peritoneal Route in Refractory Chronic Congestive Cardiac Failure.经腹膜途径超滤治疗难治性慢性充血性心力衰竭
Indian J Nephrol. 2018 Jul-Aug;28(4):298-302. doi: 10.4103/ijn.IJN_12_17.
10
Diuretic Treatment in Heart Failure.心力衰竭的利尿治疗
N Engl J Med. 2017 Nov 16;377(20):1964-1975. doi: 10.1056/NEJMra1703100.